Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation of...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of Biomolecular Aggregate Morphology and Condensate Infectivity.

Biomolecules·2026
Same author

NANOG Proximity Proteomics Maps Neighborhood Hubs Linked to Mesenchymal Stem Cell Stemness and Chromatin Control.

Biomolecules·2026
Same author

Condensate State as Determinant of Amyloid Pathology in Neurodegeneration.

Biomolecules·2026
Same author

Label-Free Microfluidic Modulation Spectroscopy Monitors RNA Origami Structure and Stability.

Biosensors·2026
Same author

Tubulin transforms Tau and α-synuclein condensates from pathological to physiological.

Nature communications·2026
Same author

Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions.

Biomolecules·2026
Same journal

Beyond Binding Affinity: How a Conformation-Specific Salt Bridge Tunes KIF1A Mechanochemistry.

Cytoskeleton (Hoboken, N.J.)·2026
Same journal

Picture of the Month by Arif Ashraf.

Cytoskeleton (Hoboken, N.J.)·2026
Same journal

Picture of the Month by Joh Demura-devore and Arif Ashraf.

Cytoskeleton (Hoboken, N.J.)·2026
Same journal

Picture of the Month by Arif Ashraf.

Cytoskeleton (Hoboken, N.J.)·2026
Same journal

Picture of the Month by Arif Ashraf.

Cytoskeleton (Hoboken, N.J.)·2026
Same journal

Picture of the Month by Julia Zheku and M. Arif Ashraf.

Cytoskeleton (Hoboken, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
07:54

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles

Published on: November 5, 2020

Tubulin State Determines Proteopathic Fate.

Lathan Lucas1, My Diem Quan1, Josephine C Ferreon1

  • 1Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas, USA.

Cytoskeleton (Hoboken, N.J.)
|June 12, 2026
PubMed
Summary
This summary is machine-generated.

Tubulin and microtubules actively influence neurodegenerative protein behavior, preventing pathological aggregation. Disruptions in this system may drive disease progression and offer new therapeutic targets.

More Related Videos

Optimizing Tubulin Yield from Porcine Brain Tissue
06:30

Optimizing Tubulin Yield from Porcine Brain Tissue

Published on: October 11, 2024

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
08:07

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jun 13, 2026

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles
07:54

Purification of Tubulin with Controlled Posttranslational Modifications and Isotypes from Limited Sources by Polymerization-Depolymerization Cycles

Published on: November 5, 2020

Optimizing Tubulin Yield from Porcine Brain Tissue
06:30

Optimizing Tubulin Yield from Porcine Brain Tissue

Published on: October 11, 2024

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
08:07

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

Area of Science:

  • Neurobiology
  • Cell Biology
  • Biochemistry

Background:

  • Neurodegenerative diseases are characterized by protein aggregation.
  • Cytoskeletal disruption is often viewed as a secondary effect.

Purpose of the Study:

  • To propose that tubulin and microtubules are active regulators of protein aggregation in neurodegeneration.
  • To explore the role of protein-microtubule interactions in disease pathogenesis.
  • To identify the tubulin/microtubule system as a therapeutic target and biomarker.

Main Methods:

  • Review of recent evidence on tubulin-protein interactions.
  • Theoretical modeling of protein binding equilibria.
  • Consideration of implications for therapy and biomarker development.

Main Results:

  • Tubulin can redirect disease-linked protein condensates away from pathological aggregation.
  • Loss of productive protein-microtubule engagement promotes pathological interactions.
  • Microtubule disruption can exacerbate neurodegenerative processes.

Conclusions:

  • The tubulin/microtubule system is a key determinant of neurodegenerative protein fate.
  • Dysfunctional protein-microtubule engagement contributes to disease progression and mixed pathologies.
  • Targeting tubulin and microtubules offers potential therapeutic and diagnostic strategies.